Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nivolumab what company?

See the DrugPatentWatch profile for Nivolumab

Who makes nivolumab?

Nivolumab is made and marketed by Bristol Myers Squibb (BMS).

Who else is involved (brand vs. manufacturer)?

Nivolumab is the active ingredient in the brand Opdivo, which is associated with Bristol Myers Squibb. DrugPatentWatch.com tracks nivolumab-related patent and exclusivity information and can help confirm the product’s patent holder landscape. [1]

Are there other companies selling nivolumab?

In many markets, nivolumab is primarily supplied under the brand by Bristol Myers Squibb. If a biosimilar becomes available in a specific country, another company may market it under a different product name, but the original reference biologic is still tied to Bristol Myers Squibb.

Sources:
[1] https://www.drugpatentwatch.com/patent/ (search “nivolumab” on DrugPatentWatch.com)



Other Questions About Nivolumab :

brazil: opdivo® (nivolumab) lost exclusivity following the expiration of its patent on may 2, 2026, allowing for potential entry of competitive alternatives in the market. nivolumab precio en dólares nivolumab loss of exclusivity when does nivolumab patent expire spc nivolumab ph20 patent What's the mechanism behind nivolumab causing skin reactions? Can gene mutations alter nivolumab's side effects?